Phil completed $56 million Series D Round funding
Sector:
Software App
Digital Health
06/03/2021
San Francisco, CA USA
"As the only technology-powered, full-suite solution addressing the specialty pharmaceuticals market, Phil uniquely provides an integrated suite of solutions to replace the historically complex and cost-prohibitive process of deploying 'hub' services. With the goal to become the gold standard for pharmaceutical access, affordability, and distribution, this investment enables us to accelerate our growth at a rapid pace and serves as a well-deserved recognition of our entire team's commitment over the past 6 years," said Deepak Thomas, Founder and CEO of Phil. "Warburg Pincus has a stellar track record of investing and scaling innovative and category-defining healthcare and technology companies. Their operational and strategic support will be invaluable as we continue to grow our platform and relentlessly work to improve the experience of our customers and patients."
About
Phil is a software-driven therapy deployment platform that provides pharmaceutical manufacturers with a modern alternative to traditional access, affordability, and distribution solutions. By integrating digital stakeholder experiences, patient access services, market access tools, and flexible distribution models, Phil enables manufacturers to deliver timely, affordable therapy access to patients.
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
